Eupraxia Financial Statements From 2010 to 2026

EPRX Stock   8.28  0.07  0.84%   
Eupraxia Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Eupraxia Pharmaceuticals' valuation are provided below:
Market Capitalization
427.8 M
Earnings Share
(0.88)
We have found one hundred twenty available fundamental signals for Eupraxia Pharmaceuticals Common, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of Eupraxia Pharmaceuticals Common prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 70.1 M in 2026. Enterprise Value is likely to drop to about 90.7 M in 2026
Check Eupraxia Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eupraxia Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 161.5 K, Interest Expense of 1 M or Selling General Administrative of 19 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 6.79. Eupraxia financial statements analysis is a perfect complement when working with Eupraxia Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with Eupraxia Stock
Check out the analysis of Eupraxia Pharmaceuticals Correlation against competitors.

Eupraxia Pharmaceuticals Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets42.2 M40.2 M14.7 M
Slightly volatile
Short and Long Term Debt Total78.5 K82.6 K3.6 M
Slightly volatile
Other Current Liabilities4.8 M2.7 M3.6 M
Slightly volatile
Total Current Liabilities2.7 M2.8 M5.7 M
Slightly volatile
Property Plant And Equipment Net550.7 K488.7 K469.5 K
Slightly volatile
Cash40 M38.1 M12.4 M
Slightly volatile
Non Current Assets Total567.6 K581.5 K483.1 K
Slightly volatile
Cash And Short Term Investments40 M38.1 M12.9 M
Slightly volatile
Net Receivables195.7 K206 K717.7 K
Slightly volatile
Common Stock Shares Outstanding19.7 M39 M17.2 M
Slightly volatile
Liabilities And Stockholders Equity42.2 M40.2 M14.7 M
Slightly volatile
Other Current Assets755.7 K1.3 M531.9 K
Slightly volatile
Total Liabilities3.4 M3.6 M7.2 M
Slightly volatile
Total Current Assets41.6 M39.6 M14.2 M
Slightly volatile
Short Term Debt61.4 K64.7 K2.3 M
Pretty Stable
Common Stock140.5 M133.8 M53.9 M
Slightly volatile
Other Assets7.6 M7.3 M2.4 M
Slightly volatile
Capital Lease Obligations92.6 K64.7 K159.2 K
Slightly volatile
Inventory1.652.31.2912
Slightly volatile
Property Plant And Equipment Gross818.8 KM592 K
Slightly volatile
Short and Long Term Debt12.6 M12 MM
Very volatile
Capital Stock86.7 M170.3 M49.3 M
Slightly volatile
Long Term Debt8.8 M10.1 M7.8 M
Slightly volatile
Current Deferred Revenue3.3 K3.7 KK
Slightly volatile

Eupraxia Pharmaceuticals Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization161.5 K284 K131 K
Slightly volatile
Interest ExpenseM998.2 K587.5 K
Slightly volatile
Selling General Administrative19 M18.1 M5.7 M
Slightly volatile
Other Operating Expenses46.9 M44.7 M14.8 M
Slightly volatile
Research Development27.9 M26.6 M9.3 M
Slightly volatile
Cost Of Revenue165.2 K241.4 K133.8 K
Slightly volatile
Total Operating Expenses46.9 M44.7 M14.7 M
Slightly volatile
Interest Income1.4 M1.3 M308.5 K
Slightly volatile
Selling And Marketing Expenses1.4 M2.7 M848.2 K
Slightly volatile
Reconciled Depreciation143.9 K197.5 K112.5 K
Slightly volatile
Minority Interest395.3 K278.2 K151.5 K
Slightly volatile

Eupraxia Pharmaceuticals Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation1.9 M3.7 M1.2 M
Slightly volatile
Begin Period Cash Flow23.4 M22.2 M6.1 M
Slightly volatile
Depreciation150.3 K197.5 K119.9 K
Slightly volatile
End Period Cash Flow40 M38.1 M11.7 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation0.480.512.4649
Slightly volatile
Cash Per Share0.560.880.5438
Slightly volatile
Income Quality0.581.050.8711
Slightly volatile
Current Ratio3.586.955.7834
Pretty Stable
Capex Per Share0.00340.00350.0175
Slightly volatile
Average ReceivablesM873.3 K942.9 K
Slightly volatile
Interest Debt Per Share0.04560.0480.2675
Slightly volatile
Debt To Assets0.00220.00240.8734
Pretty Stable
Ebt Per Ebit1.261.11.0939
Slightly volatile
Long Term Debt To Capitalization0.320.430.3498
Slightly volatile
Quick Ratio3.586.955.7834
Pretty Stable
Net Income Per E B T0.770.890.9031
Slightly volatile
Cash Ratio7.016.684.7705
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.121.151.0498
Very volatile
Debt Ratio0.00220.00240.8734
Pretty Stable

Eupraxia Pharmaceuticals Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap70.1 M137.7 M93.9 M
Slightly volatile
Enterprise Value90.7 M138 M89.4 M
Slightly volatile

Eupraxia Fundamental Market Drivers

About Eupraxia Pharmaceuticals Financial Statements

Eupraxia Pharmaceuticals investors use historical fundamental indicators, such as Eupraxia Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Eupraxia Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue3.7 K3.3 K
Cost Of Revenue241.4 K165.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Eupraxia Stock Analysis

When running Eupraxia Pharmaceuticals' price analysis, check to measure Eupraxia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eupraxia Pharmaceuticals is operating at the current time. Most of Eupraxia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eupraxia Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eupraxia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eupraxia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.